Beta Bionics (BBNX) Total Non-Current Liabilities (2023 - 2026)

Beta Bionics' Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $31.6 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 32.43% year-over-year to $31.6 million; the TTM figure through Mar 2026 stood at $31.6 million (up 32.43% YoY), while the FY2025 annual figure was $39.6 million, up 37.77% from the prior year.
• Total Non-Current Liabilities came in at $31.6 million for Q1 2026 at Beta Bionics, down from $39.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $39.6 million in Q4 2025 to a low of $23.9 million in Q1 2025.
• A 4-year average of $30.6 million and a median of $29.1 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities decreased 1.3% in 2024 and soared 37.77% in 2025, its largest moves.
• Beta Bionics' Total Non-Current Liabilities stood at $29.1 million in 2023, then fell by 1.3% to $28.7 million in 2024, then jumped by 37.77% to $39.6 million in 2025, then dropped by 20.14% to $31.6 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $31.6 million, $39.6 million, and $34.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison